Early versus late administration of pegfilgrastim after autologous hematopoietic stem cell transplantation

被引:0
|
作者
Kahl, C. [1 ]
Sayer, H. [2 ]
Hinke, A. [3 ]
Pester, F. [2 ]
Freund, M. [1 ]
Casper, J. [4 ]
机构
[1] Univ Rostock, Innere Med Klin 3, Rostock, Germany
[2] Univ Jena, Klin Innere Med 2, Jena, Germany
[3] Wissenschaftlicher Serv Pharma GmbH, Langenfeld, Germany
[4] Klin Onkol & Hamatol, Oldenburg, Germany
来源
ONKOLOGIE | 2010年 / 33卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:169 / 169
页数:1
相关论文
共 50 条
  • [1] Early versus late administration of pegfilgrastim after high-dose chemotherapy and autologous hematopoietic stem cell transplantation
    Kahl, C.
    Sayer, H. G.
    Hinke, A.
    Freund, M.
    Casper, J.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (03) : 513 - 517
  • [2] Early versus late administration of pegfilgrastim after high-dose chemotherapy and autologous hematopoietic stem cell transplantation
    C. Kahl
    H. G. Sayer
    A. Hinke
    M. Freund
    J. Casper
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 513 - 517
  • [3] Pegfilgrastim after autologous stem cell transplantation
    Rinaldi, CR
    Becchimanzi, C
    Risitano, AM
    Marra, N
    Rotoli, B
    De Rosa, G
    BONE MARROW TRANSPLANTATION, 2006, 37 : S307 - S307
  • [4] Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation
    Vanstraelen, G
    Frère, P
    Ngirabacu, MC
    Willems, E
    Fillet, G
    Beguin, Y
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (03) : 382 - 388
  • [5] Pegfilgrastim compared with filgrastim after autologous hematopoietic peripheral blood stem cell transplantation
    Vanstraelen, G.
    Frere, P.
    Ngirabacu, M. C.
    Willems, E.
    Fillet, G.
    Beguin, Y.
    ACTA CLINICA BELGICA, 2006, 61 (02): : 104 - 104
  • [6] Pegfilgrastim versus Filgrastim in autologous peripheral stem cell transplantation
    Rios-Contreras, Jose G.
    Granja-Moran, Manuel A.
    Acosta-Maldonado, Brenda L.
    Rivera-Fong, Liliana
    Valero-Saldana, Luis M.
    BONE MARROW TRANSPLANTATION, 2018, 53 : 357 - 358
  • [7] Early versus Late Fluconazole Prophylaxis in Autologous Hematopoietic Cell Transplantation
    Guarana, Mariana
    Nucci, Marcio
    Barreiros, Gloria
    Valeri, Julio
    Almeida, Cecilia
    Nouer, Simone A.
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (08): : 681.e1 - 681.e5
  • [8] Fixed dose of pegfilgrastim versus daily filgrastim after autologous stem cell transplantation
    Marcacci, G
    Petti, MC
    Ferrara, F
    Scarpato, N
    Storti, S
    D'Arena, G
    Palombi, F
    Palmieri, S
    Andretta, C
    Pinto, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S160 - S160
  • [9] PEGFILGRASTIM AFTER CONDITIONING WITH BEAM AND AUTOLOGOUS HEMATOPOIETIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN LYMPHOMA PATIENTS
    Loteta, Barbara
    Tripepi, Giovanni
    Annalisa, Pitino
    Gori, Mercedes
    Porto, Gaetana
    Utano, Giovanna
    Policastro, G.
    Santoro, Ludovica
    Mico, Maria Caterina
    Martino, Massimo
    BONE MARROW TRANSPLANTATION, 2024, 59 : 490 - 491
  • [10] Pegfilgrastim versus filgrastim to accelerate hematopoietic recovery after high-dose melphalan and autologous hematopoietic stem cell transplantation (ASCT) for multiple myeloma
    Olin, RL
    Luger, SM
    Porter, DL
    Schuster, SJ
    Tsai, D
    Nasta, S
    Perl, A
    Loren, AW
    Goldstein, S
    Mangan, P
    Sherry, V
    Cunningham, K
    Sachs, B
    Hummel, K
    Stadtmauer, EA
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 87 - 87